We are live on ! Find out more
ICRM

Insight Capital Research & Management Portfolio holdings

AUM $177M
1-Year Est. Return 72%
This Fund
S&P 500
This Quarter Est. Return
+1.35%
1 Year Est. Return
+72%
3 Year Est. Return
+286.87%
5 Year Est. Return
10 Year Est. Return
AUM
$331M
AUM Growth
-$47.5M
Cap. Flow
-$42.5M
Cap. Flow %
-12.83%
Top 10 Hldgs %
23.31%
Holding
126
New
28
Increased
18
Reduced
40
Closed
37

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.84%
2 Healthcare 23.55%
3 Technology 16.31%
4 Industrials 8.8%
5 Communication Services 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMSG
1
DELISTED
Amsurg Corp
AMSG
$10.4M 3.15%
133,974
+51,424
+62% +$3.97M
AAPL icon
2
Apple
AAPL
$4.9T
$9.9M 2.99%
359,088
-972
-0.3% -$28.5K
AMZN icon
3
Amazon
AMZN
$2.66T
$8.99M 2.72%
351,240
-23,440
-6% -$593K
ICLR icon
4
Icon
ICLR
$13.1B
$8.74M 2.64%
123,145
+27,382
+29% +$2.06M
META icon
5
Meta Platforms (Facebook)
META
$1.64T
$6.87M 2.08%
76,380
+23,467
+44% +$2.15M
INFN
6
DELISTED
Infinera Corporation Common Stock
INFN
$6.78M 2.05%
346,523
+33,216
+11% +$724K
IWV icon
7
iShares Russell 3000 ETF
IWV
$19.6B
$6.72M 2.03%
+59,000
New +$7.14M
MOH icon
8
Molina Healthcare
MOH
$11.7B
$6.44M 1.95%
93,481
-3,343
-3% -$248K
EPAM icon
9
EPAM Systems
EPAM
$4.63B
$6.32M 1.91%
84,766
-3,880
-4% -$280K
ORLY icon
10
O'Reilly Automotive
ORLY
$71.3B
$5.93M 1.79%
355,920
+305,940
+612% +$4.94M
WOOF
11
DELISTED
VCA Inc.
WOOF
$5.9M 1.78%
112,117
-4,702
-4% -$263K
EBS icon
12
Emergent Biosolutions
EBS
$394M
$5.88M 1.78%
+206,459
New +$6.8M
CBM
13
DELISTED
Cambrex Corporation
CBM
$5.65M 1.71%
142,305
+68,630
+93% +$3.21M
STMP
14
DELISTED
Stamps.com, Inc.
STMP
$5.55M 1.68%
75,053
+18,960
+34% +$1.47M
AMN icon
15
AMN Healthcare
AMN
$1.36B
$5.37M 1.62%
178,885
-112,811
-39% -$3.72M
NCLH icon
16
Norwegian Cruise Line
NCLH
$8.93B
$5.34M 1.62%
93,238
+1,084
+1% +$63.9K
ACHC icon
17
Acadia Healthcare
ACHC
$3.17B
$5.31M 1.61%
80,128
+34,484
+76% +$2.65M
IDTI
18
DELISTED
Integrated Device Technology I
IDTI
$5.3M 1.6%
261,175
-71,437
-21% -$1.4M
REGN icon
19
Regeneron Pharmaceuticals
REGN
$70.9B
$5.22M 1.58%
11,221
+2,745
+32% +$1.47M
ABMD
20
DELISTED
Abiomed Inc
ABMD
$5.17M 1.56%
+55,724
New +$4.91M
QLIK
21
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
$5.13M 1.55%
+140,826
New +$5.44M
SBUX icon
22
Starbucks
SBUX
$120B
$5.02M 1.52%
88,358
-148
-0.2% -$8.29K
SKX
23
DELISTED
Skechers
SKX
$4.99M 1.51%
111,609
+41,823
+60% +$1.9M
ELLI
24
DELISTED
Ellie Mae Inc
ELLI
$4.99M 1.51%
74,919
-18,794
-20% -$1.39M
BLKB icon
25
Blackbaud
BLKB
$1.49B
$4.82M 1.46%
85,816
-4,811
-5% -$282K

Similar funds

Insight Capital Research & Management's Q3 2015 Portfolio in Review

As of Q3 2015, Insight Capital Research & Management held 126 positions worth $331M, down 13% from $378M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Insight Capital Research & Management withdrew a net $42.5M in Q3 2015, closing 37 positions and reducing 40 holdings. Its most notable exit was Gigamon Inc., an estimated $9.52M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Insight Capital Research & Management opened a new position in iShares Russell 3000 ETF worth $6.72M.

  • Insight Capital Research & Management's largest Q3 2015 buy was iShares Russell 3000 ETF: 59,000 shares worth $6.72M.
  • Insight Capital Research & Management added most to O'Reilly Automotive in Q3 2015, an estimated $4.94M increase.
  • Insight Capital Research & Management's biggest Q3 2015 reduction was Dycom Industries, cutting an estimated $5.36M.
  • Insight Capital Research & Management fully exited Gigamon Inc. in Q3 2015, selling an estimated $9.52M.
  • Insight Capital Research & Management's ten largest holdings make up 23% of its $331M portfolio in Q3 2015.
  • Insight Capital Research & Management opened 28 new positions and closed 37 in Q3 2015.
  • Insight Capital Research & Management's portfolio value fell 13% quarter-over-quarter to $331M.

Based on Insight Capital Research & Management's 13F filing for Q3 2015, filed 5 Nov 2015.